TSS
MRNS

Two Sigma Securities’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Two Sigma Securities’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,924
Closed -$29K – 1001
2016
Q3 		$29K Buy
+3,924
New +$26.5K 0.01% 587

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Two Sigma Securities's MRNS Position: Q4 2016 in Review

Two Sigma Securities sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2016, closing a stake of 3,924 shares — an estimated $29K sold.

Two Sigma Securities first reported a position in MRNS in Q3 2016 and held it in 1 quarter. The position peaked at $29K in Q3 2016. 23 funds tracked by Wall St. Rank hold MRNS as of Q4 2016.

  • Two Sigma Securities reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2016 after selling out during the quarter.
  • Two Sigma Securities sold 3,924 Marinus Pharmaceuticals, Inc shares in Q4 2016, an estimated $29K.
  • Two Sigma Securities first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 1 quarter.
  • Two Sigma Securities's Marinus Pharmaceuticals, Inc position peaked at $29K in Q3 2016.
  • 23 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2016.

Based on Two Sigma Securities's 13F filing for Q4 2016, filed 14 Feb 2017.